1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Par Pacific reported second quarter 2025 net income of $59.5 million, or $1.17 per diluted share, up from $18.6 million, or $0.32 per diluted share, a year earlier. Revenue fell to $1.89 billion from $2.02 billion, and Adjusted EBITDA rose 69% to $137.8 million, so headline results point in opposite directions. The company also repurchased $28 million of common stock and announced a Hawaii Renewables joint venture with expected cash proceeds of $100 million.
Net income was $59.5 million ($1.17 per diluted share) versus $18.6 million ($0.32) in Q2 2024.
Revenues were $1,893.4 million versus $2,017.5 million in Q2 2024.
Adjusted EBITDA was $137.8 million, a 69% improvement from $81.6 million.
The company repurchased $28 million of common stock at an average price of $17.36 per share in the quarter.
Mosaic reported results for the quarter ended June 30, 2025, in a press release dated August 5, 2025, with supporting performance data furnished as Exhibit 99.2. Net earnings attributable to Mosaic were $411 million, against a loss of $162 million a year earlier, and net sales rose to $3,005 million from $2,817 million. Adjusted diluted EPS of $0.51 was below $0.54 in Q2 2024, and adjusted EBITDA of $566 million was below $584 million, so shareholders see a mixed picture driven partly by notable items.
Diluted EPS of $1.29 in Q2 2025, versus a loss of $0.50 per share in Q2 2024
Notable items added $0.78 per share in Q2 2025, including a $216 million Ma'aden mark-to-market gain
Adjusted diluted EPS of $0.51, down from $0.54 in Q2 2024 but up from $0.49 in Q1 2025
Gross margin rate of 17% in Q2 2025, up from 14% a year earlier
Chemours reported second quarter 2025 net sales of $1.6 billion, up 4% from a year earlier, but swung to a net loss of $381 million, or $2.54 per diluted share, from net income of $60 million a year earlier. The company said the loss was driven mainly by litigation charges tied to its New Jersey PFAS settlement, while adjusted net income rose to $87 million, or $0.58 per share.
Net sales were $1.6 billion, up 4% from $1,554 million in Q2 2024
Net loss attributable to Chemours was $381 million, or $2.54 per diluted share, versus net income of $60 million, or $0.39, in Q2 2024
Adjusted net income was $87 million, or $0.58 per diluted share, versus $58 million, or $0.38, a year earlier
Full-year 2025 Adjusted EBITDA is expected to be $775 million to $825 million, and Q3 2025 Adjusted EBITDA $175 million to $195 million
Noble reported second quarter 2025 total revenue of $849 million, down from $874 million in the first quarter but up from $693 million a year earlier. Net income fell to $43 million, or $0.27 per diluted share, from $108 million in the first quarter and $195 million in the second quarter of 2024. The company lowered its 2025 total revenue guidance to $3,200 million to $3,300 million but raised its Adjusted EBITDA guidance to $1,075 million to $1,150 million.
Q2 2025 total revenue was $849 million, versus $874 million in Q1 2025 and $693 million in Q2 2024.
Q2 2025 net income was $43 million, or $0.27 per diluted share, versus $108 million in Q1 2025 and $195 million in Q2 2024.
2025 total revenue guidance was cut to $3,200 million to $3,300 million from $3,250 million to $3,450 million; Adjusted EBITDA guidance was raised to $1,075 million to $1,150 million from $1,050 million to $1,150 million.
The board approved a $0.50 per share Q3 2025 dividend, payable September 25, 2025, to shareholders of record on September 4, 2025.
StoneX reported fiscal third-quarter results for the period ended June 30, 2025, with net operating revenues of $488.3 million, up 4%, and net income of $63.4 million, up 2%. Diluted EPS fell 2% to $1.22 from $1.25, and the company cited $8.9 million in acquisition-related charges, about $0.12 per diluted share, as a drag on the quarter.
Net operating revenues were $488.3 million, up 4%, and net income was $63.4 million, up 2%.
Diluted EPS was $1.22 versus $1.25 a year earlier, down 2%; the company cited $8.9 million in acquisition-related charges, about $0.12 per diluted share.
Acquisitions of R.J. O'Brien and The Benchmark Company, LLC closed on July 31, 2025, after the quarter ended.
A conference call is scheduled for 9:00 a.m. Eastern on August 6, 2025, and the full Form 10-Q is to follow.
Innovex reported second-quarter 2025 revenue of $224 million, down 7% from the prior quarter, and net income of $15 million. The company guided to third-quarter 2025 revenue of $230-$240 million and Adjusted EBITDA of $40-$45 million, and said it closed the $70 million all-cash Citadel Casing Solutions acquisition on May 30.
Q2 2025 revenue of $224 million, down 7% quarter over quarter; net income of $15 million
Q2 operating cash flow of $59 million and free cash flow of $52 million
Q3 2025 guidance: total revenue of $230-$240 million and Adjusted EBITDA of $40-$45 million
Citadel acquisition closed May 30 for $70 million in cash; Eldridge facility sale targeted to close in Q3 2025
Acadia Healthcare reported second-quarter 2025 revenue of $869.2 million, up 9.2% from a year earlier, but net income attributable to the company fell to $30.1 million, or $0.33 per diluted share, from $78.5 million, or $0.85. The company also updated its 2025 guidance and said CFO Heather Dixon will step down effective August 15, 2025, with Senior Vice President Tim Sides named interim CFO effective August 16, 2025.
Q2 2025 revenue $869.2 million, up 9.2%; adjusted EPS $0.83 versus $0.91 in Q2 2024
Net income attributable to Acadia $30.1 million, or $0.33 per diluted share, versus $78.5 million, or $0.85, a year earlier
2025 guidance: revenue $3.3 billion to $3.35 billion; adjusted EPS $2.45 to $2.65; startup losses $60 million to $65 million, a $10 million increase
CFO Heather Dixon resigns effective August 15, 2025; Tim Sides becomes interim CFO effective August 16, 2025 at a $445,000 base salary
Resideo reported second quarter 2025 net revenue of $1.94 billion, up 22% from a year earlier, and adjusted EBITDA of $210 million, up 20%. The company also posted a net loss of $825 million, driven by an $882 million expense tied to its agreement with Honeywell to terminate the Indemnification Agreement, and raised its full-year 2025 outlook. Shareholders will see both the strong operating results and the large one-time charge, with a further one-time payment to Honeywell of $1.59 billion due in the third quarter upon closing.
Net revenue was $1,943 million, up 22% from $1,589 million; adjusted EBITDA was $210 million, up 20% from $175 million.
GAAP diluted loss per share was $(5.59), compared with $0.19 a year earlier; adjusted EPS was $0.66, compared with $0.62.
The net loss reflects an $882 million expense tied to the Honeywell agreement; a $1.59 billion one-time cash payment to Honeywell is due in the third quarter of 2025 upon closing.
The company raised its 2025 outlook, with full-year net revenue now $7,450 million to $7,550 million and adjusted EBITDA of $845 million to $885 million.
IFF reported second-quarter 2025 net sales of $2.76 billion, down 4% from a year earlier, while reported diluted EPS was $2.38 versus $0.66 a year earlier. The company reaffirmed its full-year 2025 guidance, authorized a $500 million share repurchase program with no set end date, and agreed to sell its soy crush, concentrates and lecithin business to Bunge, which the company said generated about $240 million in 2024 revenue. For shareholders, first-half results include a $1,153 million goodwill impairment that produced a $405 million net loss for the six months.
Q2 net sales $2.76 billion, down 4% reported; up 3% on a comparable currency-neutral basis
Q2 reported diluted EPS $2.38 versus $0.66 a year earlier; first-half EPS was a loss of $1.59
Board authorized up to $500 million in share repurchases with no specified term or termination date
Full-year 2025 guidance reaffirmed: sales of $10.6 billion to $10.9 billion and adjusted operating EBITDA of $2 billion to $2.15 billion
Powell Industries reported fiscal third-quarter 2025 revenue of $286.3 million, down 1% from a year earlier, while net income rose 4% to $48.2 million, or $3.96 per diluted share. The company also declared a quarterly cash dividend of $0.2675 per share and announced a definitive agreement to acquire Remsdaq Ltd. after quarter end.
Revenue was $286.3 million versus $288.2 million a year earlier, a 1% decline; gross profit rose 8% to $87.9 million
Net income was $48.2 million, or $3.96 per diluted share, compared with $3.79 a year earlier
Backlog reached $1.4 billion as of June 30, 2025, up 5% from June 30, 2024
Dividend of $0.2675 per share is payable September 17, 2025 to holders of record on August 20, 2025
Jackson Financial reported second quarter 2025 net income attributable to common shareholders of $168 million, or $2.34 per diluted share, down from $264 million, or $3.43, a year earlier. Adjusted operating earnings, which the company says better reflect underlying performance, fell to $350 million, or $4.87 per share, from $410 million, or $5.32. Retail annuity sales rose 4% to $4.4 billion and free cash flow increased to $290 million, but lower earnings reflect a weaker quarter for shareholders.
Net income attributable to common shareholders was $168 million, or $2.34 per diluted share, versus $264 million, or $3.43, in Q2 2024.
Adjusted operating earnings were $350 million, or $4.87 per diluted share, versus $410 million, or $5.32, in Q2 2024.
Retail annuity sales rose 4% to $4.4 billion, and free cash flow was $290 million versus $229 million in Q2 2024.
The company returned $216 million to common shareholders in the quarter, including $158 million in share repurchases; a conference call is set for August 6, 2025, at 11 a.m. ET.
Gulfport reported second-quarter 2025 net income of $184.5 million, compared with a net loss of $26.2 million a year earlier, on total revenues of $447.6 million. The company also raised its stock repurchase authorization by 50% to $1.5 billion and plans to redeem all outstanding Series A Convertible Preferred Stock for cash on September 5, 2025, while warning that full-year 2025 production is trending toward the low end of its guidance range.
Q2 2025 net income was $184.5 million versus a net loss of $26.2 million in Q2 2024; total revenues were $447.6 million versus $181.1 million.
Full-year 2025 production is now forecast to trend toward the low end of guidance, as midstream capacity projects remain ongoing.
Stock repurchase authorization expanded to $1.5 billion through December 31, 2026; about $790.9 million remains, and 31,356 preferred shares are outstanding for redemption on September 5, 2025.
GXO Logistics reported second quarter 2025 revenue of $3.3 billion, up 16% year over year, and raised its full-year 2025 adjusted EBITDA guidance to $865 million to $885 million. GAAP net income fell to $28 million from $39 million, while adjusted diluted EPS rose to $0.57 from $0.55. CFO Baris Oran also plans to step down, which adds leadership change to the picture for shareholders.
Revenue was $3.3 billion, up 16% from $2.8 billion a year earlier; organic revenue growth was 6%.
Net income was $28 million versus $39 million; diluted EPS was $0.23 versus $0.32. Adjusted diluted EPS was $0.57 versus $0.55.
Full-year 2025 adjusted EBITDA guidance was raised to $865 million to $885 million.
CFO Baris Oran plans to step down to pursue new opportunities and will remain until a successor is named.
Supernus reported second-quarter 2025 total revenues of $165.5 million, down 2% from $168.3 million a year earlier, while diluted earnings per share rose to $0.40 from $0.36 and net earnings were $22.5 million. It raised full-year 2025 revenue guidance to $670 million-$700 million and moved its GAAP operating earnings guidance to a loss of $70 million-$80 million, citing the Sage Therapeutics acquisition completed July 31, 2025. For shareholders, quarterly profit improved, but revenue slipped and the GAAP operating outlook worsened.
Q2 2025 total revenues were $165.5 million, versus $168.3 million in Q2 2024; Qelbree net sales rose 31% to $77.6 million.
Q2 2025 net earnings were $22.5 million, or $0.40 per diluted share, versus $0.36 a year earlier; six-month diluted EPS was $0.19 versus $0.36.
Full-year 2025 total revenue guidance is $670 million-$700 million, up from $600 million-$630 million.
Full-year 2025 GAAP operating earnings (loss) guidance is $(70) million to $(80) million, down from $(15) million to $10 million.
Voya Financial reported second-quarter 2025 net income available to common shareholders of $162 million, or $1.66 per diluted share, down from $201 million, or $1.96 per diluted share, a year earlier. After-tax adjusted operating earnings rose to $240 million, or $2.46 per diluted share, from $223 million, or $2.18, as the company cited earnings from the business acquired from OneAmerica. The GAAP decline reflected investment losses and severance expenses, and total revenues fell to $1,981 million from $2,033 million.
Net income available to common shareholders: $162 million ($1.66 per diluted share) vs. $201 million ($1.96) in Q2 2024
After-tax adjusted operating earnings: $240 million ($2.46 per diluted share) vs. $223 million ($2.18) in Q2 2024
Total revenues: $1,981 million vs. $2,033 million; net losses on investments were $41 million vs. $4 million a year earlier
Returned $44 million to shareholders through common dividends in the quarter; about $0.3 billion of excess capital as of June 30, 2025
Stride reported results for the fourth quarter and fiscal year ended June 30, 2025. Fiscal 2025 revenue rose 17.9% to $2.41 billion and net income rose 41.0% to $287.9 million, while fourth-quarter revenue grew 22.4% but GAAP net income fell 18.3% to $51.3 million after a $59.5 million impairment charge tied to its Galvanize business. The charge reduced reported profit in the quarter, though the company's adjusted earnings per share rose to $2.29 from $1.68.
Fiscal 2025 revenue was $2,405.3 million, up from $2,040.1 million, and net income was $287.9 million, up from $204.2 million.
Fourth-quarter revenue was $653.6 million, up 22.4%, while net income was $51.3 million, down 18.3% from $62.8 million.
The $59.5 million impairment charge for the Galvanize business was excluded from adjusted measures; fourth-quarter diluted EPS was $1.03 versus $1.42, and adjusted EPS was $2.29 versus $1.68.
Full-year enrollments averaged 234.0K, up 20.4%; cash and marketable securities totaled $1,011.4 million at June 30, 2025.
Match Group reported second-quarter 2025 revenue of $864 million, flat year over year, and adjusted operating income of $290 million, down 5%, after a $14 million legal settlement charge it described as unanticipated. The company guided third-quarter revenue to $910 million to $920 million, up 2% to 3%, and adjusted operating income to $330 million to $335 million, down 3%, and declared a $0.19 per share dividend.
Q2 2025 paying users fell 5% year over year to 14.1 million, while revenue per payer rose 5% to $20.00.
Q3 2025 guidance: total revenue of $910 million to $920 million and adjusted operating income of $330 million to $335 million.
Board declared a $0.19 per share cash dividend payable October 17, 2025 to holders of record as of October 3, 2025.
QuidelOrtho reported second-quarter 2025 revenue of $614 million, down from $637 million a year earlier, and a GAAP net loss of $255 million, or $3.77 per diluted share, versus a $148 million loss in the prior-year quarter. The loss includes $179 million in mostly non-cash restructuring, integration and other charges, while adjusted diluted EPS rose to $0.12 from a loss of $0.07 and adjusted EBITDA rose to $107 million from $90 million. The company reiterated its full-year 2025 guidance.
Total revenue was $614 million versus $637 million, down about 4%, mainly due to lower COVID-19 and Donor Screening revenue.
GAAP diluted loss per share was $3.77 versus $2.20 a year earlier; GAAP net loss was $255 million.
Adjusted diluted EPS was $0.12 versus a loss of $0.07; adjusted EBITDA margin was 17%, a 330 basis point improvement.
Full-year 2025 guidance was reiterated, including total revenue of $2.60 to $2.81 billion and adjusted diluted EPS of $2.07 to $2.57.
Douglas Emmett reported second-quarter 2025 results for the period ended June 30, 2025. Revenue rose to $252.4 million from $245.8 million a year earlier, but the company posted a net loss attributable to common stockholders of $5.8 million, compared with net income of $10.9 million in the prior-year quarter. FFO per fully diluted share fell to $0.37 from $0.46, and the company now expects 2025 diluted net income per share of $0.07 to $0.11 and FFO per share of $1.43 to $1.47.
Total revenues were $252.4 million for Q2 2025, up from $245.8 million in Q2 2024.
Net loss attributable to common stockholders was $5.8 million, or $0.04 per share, versus net income of $10.9 million a year earlier.
FFO per fully diluted share was $0.37, down from $0.46; AFFO was $54.5 million, down from $74.2 million.
The company now expects 2025 diluted net income per share of $0.07 to $0.11 and narrowed its FFO per share guidance to $1.43 to $1.47.
Jazz reported second-quarter 2025 total revenues of $1.05 billion, up 2% from a year earlier, but posted a GAAP net loss of $718.5 million after a $905.4 million acquired in-process R&D charge tied to the Chimerix acquisition. The company lowered the top end of its full-year 2025 revenue guidance to $4.15 billion to $4.30 billion and named Renee Gala President and CEO effective August 11, 2025.
Q2 2025 total revenues were $1.05 billion, up from $1.02 billion in Q2 2024.
GAAP net loss was $718.5 million, or $11.74 per diluted share, versus GAAP net income of $168.6 million, or $2.49 per share, in Q2 2024.
The net loss includes a $905.4 million acquired IPR&D charge for dordaviprone, which reduced results by $14.78 per share on a GAAP basis.
2025 total revenue guidance is now $4.15 billion to $4.30 billion, down from $4.15 billion to $4.40 billion at the top end; GAAP net loss guidance is $(565) million to $(450) million.
Safehold reported results for the quarter ended June 30, 2025, in an earnings release and presentation published August 5, 2025. Revenue rose 4% from a year earlier to $93.8 million, but GAAP earnings per share fell 6% to $0.39, which the company attributed mainly to a $1.7 million increase in non-cash general provisions for credit losses. For shareholders, higher revenue was offset by lower per-share earnings.
Total revenue was $93.8 million, up from $89.9 million in Q2 2024.
GAAP EPS was $0.39, down from $0.42; net income attributable to common shareholders was $27.9 million, down from $29.7 million.
Non-cash general provision for credit losses was $2.4 million in Q2 2025, compared with $0.6 million in Q2 2024.
Q2 2025 originations totaled $220 million: four new ground leases for $123 million and three new leasehold loans for $97 million.
Kemper Corporation reported second quarter 2025 results on August 5, 2025. Total revenues rose $95.7 million year over year to $1,225.6 million, but net income attributable to Kemper shareholders fell to $72.6 million, or $1.12 per diluted share, from $75.4 million, or $1.16, a year earlier. Adjusted net operating income also declined, to $84.1 million, or $1.30 per diluted share, from $91.7 million, or $1.42.
Total revenues were $1,225.6 million, up $95.7 million from the second quarter of 2024, mainly from higher Specialty Property & Casualty earned premiums.
Net income attributable to Kemper was $72.6 million, or $1.12 per diluted share, versus $75.4 million, or $1.16, in the second quarter of 2024.
Specialty P&C underlying combined ratio was 93.6 percent, compared with 89.6 percent a year earlier, driven mainly by higher claim severity.
Parent liquidity was approximately $1.1 billion, and Kemper repurchased $80 million of stock between April 1 and July 31, 2025.
DaVita reported second-quarter 2025 results with revenue of $3.380 billion, up from $3.187 billion a year earlier. Net income attributable to DaVita fell to $199 million from $223 million, while diluted earnings per share rose to $2.58 from $2.50, helped by a lower share count. The company also issued $1.0 billion of 6.75% senior notes and repurchased 3.1 million shares for $446 million.
Q2 2025 revenue was $3.380 billion versus $3.187 billion in Q2 2024; operating income was $538 million versus $506 million.
Diluted EPS was $2.58 (adjusted $2.95) versus $2.50 a year earlier; net income attributable to DaVita was $199 million versus $223 million.
Cybersecurity incident charges were about $13.5 million in the quarter, and debt expense rose to $146 million from $98 million.
BlackLine reported second quarter 2025 results on August 5, 2025, with revenue up 7% to $172.0 million, but GAAP net income attributable to BlackLine fell to $8.3 million, or $0.13 per diluted share, from $76.7 million, or $0.22, a year earlier. The prior-year figure included a gain on extinguishment of convertible senior notes, and non-GAAP net income also declined to $37.9 million, or $0.51 per share, from $42.9 million, or $0.58. The company also issued third quarter and full year 2025 guidance, with full year GAAP revenue expected at $696 million to $705 million.
Total GAAP revenue of $172.0 million in Q2 2025, up 7% from the prior-year quarter; billings of $182.3 million, up 11%
GAAP net income attributable to BlackLine of $8.3 million ($0.13 per diluted share) versus $76.7 million ($0.22) in Q2 2024, which included a gain on extinguishment of convertible senior notes
Q3 2025 GAAP revenue guidance of $177 million to $179 million; full year 2025 non-GAAP net income guidance of $159 million to $167 million, or $2.13 to $2.24 per share
Repurchased about 0.8 million shares for $43.3 million; about $111.2 million of buyback capacity remained at June 30, 2025
Adeia reported second-quarter 2025 revenue of $85.7 million, down from $87.4 million a year earlier and $87.7 million in the first quarter. GAAP diluted EPS rose to $0.15 from $0.07, helped by a $9.1 million income tax benefit, while non-GAAP diluted EPS fell to $0.25 from $0.28, so shareholders see a mixed picture.
Q2 2025 revenue was $85.7 million versus $87.4 million in Q2 2024
GAAP net income was $16.7 million versus $8.4 million a year earlier; non-GAAP diluted EPS was $0.25 versus $0.28
Adjusted EBITDA was $45.7 million versus $52.8 million in Q2 2024
Full-year 2025 GAAP net income outlook raised to $85.1 to $86.5 million from $76.5 to $81.6 million; revenue outlook of $390 to $430 million reiterated
Grocery Outlet reported second quarter fiscal 2025 results for the period ended June 28, 2025, with net sales up 4.5% to $1.18 billion but GAAP net income down to $5.0 million from $14.0 million, weighed by $11.2 million in restructuring charges. The company raised its fiscal 2025 diluted adjusted earnings per share guidance to $0.75 to $0.80 from $0.70 to $0.75 and maintained its other guidance figures, so the profit outlook improved even as reported second quarter earnings declined.
Net sales rose 4.5% to $1.18 billion and comparable store sales increased 1.1%.
Net income was $5.0 million, or $0.05 per diluted share, versus $14.0 million, or $0.14, a year earlier.
Diluted adjusted EPS for fiscal 2025 guidance raised to $0.75 to $0.80 from $0.70 to $0.75; net sales guidance of $4.7 billion to $4.8 billion unchanged.
Restructuring Plan total costs estimated at approximately $63 million, of which approximately $39 million is expected to be cash expenditures.
Viasat reported first quarter fiscal 2026 results, with revenue up 4% year over year to $1.2 billion and Adjusted EBITDA up 1% to $408 million. The net loss widened to $56 million from $33 million a year earlier, mainly due to higher depreciation and amortization and a higher income tax provision, so shareholders see top-line growth alongside a larger loss.
Q1 FY2026 revenue of $1.2 billion, up 4% year over year, led by a 15% rise in Defense and Advanced Technologies revenue
Net loss of $56 million, compared with $33 million in Q1 FY2025
Adjusted EBITDA of $408 million, up 1%; full-year Adjusted EBITDA outlook of flattish year over year was kept
Capital expenditure guidance for FY2026 cut to approximately $1.2 billion, an improvement of $100 million from prior guidance
Pacira BioSciences reported second-quarter 2025 total revenue of $181.1 million, up from $178.0 million a year earlier, but swung to a GAAP net loss of $4.8 million from net income of $18.9 million. The company narrowed its full-year 2025 revenue guidance to $730 million to $750 million and raised its non-GAAP gross margin guidance to 78 to 80 percent, while non-GAAP net income and adjusted EBITDA both declined year over year.
Total revenue $181.1 million versus $178.0 million in Q2 2024; EXPAREL net product sales $142.9 million.
GAAP net loss of $4.8 million, or $0.11 per share, versus GAAP net income of $18.9 million, or $0.41 per share (basic), in Q2 2024.
Non-GAAP net income $36.0 million, or $0.74 per share (diluted), versus $44.2 million, or $0.89 per share (diluted), a year earlier.
Full-year 2025 revenue guidance narrowed to $730 million to $750 million from $725 million to $765 million; non-GAAP gross margin guidance raised to 78 to 80 percent from 76 to 78 percent.
Otter Tail reported second-quarter 2025 diluted EPS of $1.85, down from $2.07 a year earlier, on revenue of $333.0 million versus $342.3 million. The company raised its 2025 diluted EPS guidance to $6.06 to $6.46 from $5.68 to $6.08, driven by a higher outlook for its Plastics segment, so shareholders face weaker recent quarterly results alongside a higher annual earnings outlook.
Q2 2025 diluted EPS was $1.85 versus $2.07 in Q2 2024; net income was $77.7 million versus $87.0 million.
2025 diluted EPS guidance rose to $6.06 to $6.46 from $5.68 to $6.08, with the Plastics segment guidance raised to $3.64 to $3.88.
Manufacturing net income fell 49.1% to $3.5 million and Plastics net income fell 12.4% to $53.1 million in the quarter.
Board declared a quarterly dividend of $0.525 per share, payable September 10, 2025 to holders of record on August 15, 2025.
Ryman Hospitality Properties reported second quarter 2025 total revenue of $659.5 million, up 7.5% from a year earlier, but net income fell 27.6% to $75.9 million and net income available to common stockholders per diluted share fell 32.1% to $1.12. The company revised its 2025 outlook: the midpoint for net income available to common stockholders per diluted share dropped to $3.47 from $3.93, while the consolidated Adjusted EBITDAre midpoint rose to $790 million from $775 million, reflecting the June 10 acquisition of the JW Marriott Desert Ridge and transient rate risk in Nashville.
Total revenue was $659.5 million, up 7.5%, with Entertainment segment revenue of $143.3 million, an all-time quarterly record.
Net income was $75.9 million, down 27.6%; diluted EPS was $1.12 versus $1.65 a year earlier.
2025 guidance: diluted EPS midpoint lowered to $3.47 from $3.93; consolidated Adjusted EBITDAre midpoint raised to $790 million from $775 million.
Same-store Hospitality Adjusted EBITDAre midpoint cut to $690 million from $695 million; $625 million of 6.500% senior notes due 2033 were sold to help fund the acquisition.
Dana reported second-quarter 2025 continuing-operations sales of $1.95 billion, down from $2.05 billion, while adjusted EBITDA rose to $145 million from $110 million and the pre-tax loss narrowed to $24 million from $53 million. The company raised its full-year 2025 guidance for continuing operations and announced a definitive agreement to sell its Off-Highway business for a $2.7 billion purchase price. For shareholders, the filing also describes a $1 billion capital return authorization and about $600 million of planned 2025 returns.
Q2 2025 sales of $1.95 billion vs. $2.05 billion a year earlier; loss before tax of $24 million vs. $53 million
Full-year 2025 continuing-operations guidance: sales of $7.25 billion to $7.55 billion and adjusted EBITDA of $540 million to $610 million
Off-Highway sale: $2.7 billion purchase price, $2.4 billion net cash proceeds, expected to close late in the fourth quarter of 2025
Repurchased 14.6 million shares in Q2; $1 billion capital return authorization with about $600 million expected in 2025
NNN REIT reported second quarter 2025 revenue of $226.8 million, up from $216.8 million a year earlier, and diluted net earnings of $0.54 per share, down from $0.58. Core FFO per share rose to $0.84 from $0.83, and the company raised its 2025 Core FFO and AFFO per share guidance, though its net earnings per share guidance (excluding certain gains, impairments and severance costs) was lowered. Shareholders get higher operating-based per-share measures and a 3.4% dividend increase, but lower reported GAAP earnings per share.
Q2 2025 revenue $226.8 million vs. $216.8 million in Q2 2024; diluted net earnings $0.54 per share vs. $0.58
Q2 2025 Core FFO per share $0.84 (vs. $0.83) and AFFO per share $0.85 (vs. $0.84)
2025 Core FFO per share guidance raised to $3.34-$3.39 from $3.33-$3.38; net earnings per share guidance lowered to $1.93-$1.98 from $1.97-$2.02
Third quarter 2025 dividend raised 3.4% to $0.60 per share, the 36th consecutive annual increase
Uniti Group reported second quarter 2025 revenue of $300.7 million, up from $294.9 million a year earlier, but posted a net loss of $10.7 million compared with net income of $17.6 million in the same period of 2024. The company also completed its merger with Windstream on August 1, 2025, and updated its full-year 2025 outlook to include Windstream's expected results for the five months after closing.
Q2 2025 revenue was $300.7 million versus $294.9 million in Q2 2024; net loss to common shareholders was $10.7 million, or $0.04 per diluted share, compared with a profit of $0.07 per share a year earlier.
Adjusted EBITDA was $242.6 million, and AFFO was $0.36 per diluted share for the quarter.
Windstream merger closed August 1, 2025; Legacy Uniti shareholders hold about 62% of the company's common stock and Windstream shareholders about 38%.
Full-year 2025 outlook: revenue of $2,215 million to $2,265 million, net loss attributable to common shareholders of $125 million to $75 million, and Adjusted EBITDA of $1,110 million to $1,160 million.
Novanta reported second-quarter 2025 results, with GAAP revenue up 2% to $241 million but GAAP net income down to $4.5 million from $13.8 million a year earlier. Adjusted diluted EPS rose to $0.76 from $0.73, and the company updated its full-year 2025 guidance and gave third-quarter guidance. The mix of higher revenue and adjusted earnings alongside a sharp fall in GAAP profit and operating cash flow leaves the picture mixed for shareholders.
GAAP revenue rose 2.2% to $241.0 million; organic revenue growth was (2.1)%, with acquisitions adding 2.3% and currency adding 2.0%.
GAAP diluted EPS was $0.12 versus $0.38, and GAAP operating income was $14.9 million versus $25.7 million, with restructuring, acquisition and related costs of $12.6 million.
Adjusted diluted EPS was $0.76 versus $0.73, and adjusted EBITDA was $52.2 million versus $51.1 million.
Full-year 2025 guidance: GAAP revenue of $970 million to $985 million, adjusted EBITDA of $225 million to $230 million, and adjusted diluted EPS of $3.22 to $3.36. Third-quarter guidance: revenue of $244 million to $247 million and adjusted
Knife River reported second-quarter 2025 revenue of $833.8 million, up 3%, but net income fell 35% to $50.6 million and diluted EPS fell to $0.89 from $1.37. The company revised full-year 2025 adjusted EBITDA guidance to $475 million to $525 million, citing wet weather, weak demand in Oregon and July flooding in Texas, which matters to shareholders because it reflects a weaker outlook for the year.
Q2 revenue $833.8 million, up 3% from $806.9 million; adjusted EBITDA $140.8 million, down 9%
Net income $50.6 million versus $77.9 million a year earlier; diluted EPS $0.89 versus $1.37
Record backlog of $1.3 billion at June 30, 2025, up nearly 30% from a year earlier
Full-year 2025 adjusted EBITDA guidance set at $475 million to $525 million
Organon reported second-quarter 2025 revenue of $1.594 billion, down 1% from a year earlier, and GAAP diluted earnings per share of $0.56 versus $0.75. The company raised its full-year 2025 revenue guidance to $6.275 billion to $6.375 billion, while affirming its Adjusted EBITDA margin range of 31.0% to 32.0%.
Q2 2025 revenue was $1.594 billion versus $1.607 billion in Q2 2024; net income was $145 million versus $195 million.
Non-GAAP Adjusted diluted EPS was $1.00 versus $1.12; GAAP diluted EPS of $0.56 includes a $46 million gain on early debt extinguishment.
Full-year 2025 revenue guidance rose to $6.275 billion to $6.375 billion from $6.125 billion to $6.325 billion, based on current foreign exchange views.
The company repaid $345 million of long-term debt in the quarter and is on track for a net debt to Adjusted EBITDA ratio below 4.0x by year-end.
Cummins reported second quarter 2025 results on August 5, 2025, with net income attributable to the company up to $890 million from $726 million a year earlier, while revenue fell 2% to $8.6 billion. The company will not reinstate a full-year 2025 outlook for revenue or profitability, citing continued economic uncertainty, and it raised its quarterly dividend from $1.82 to $2.00 per share.
Diluted EPS was $6.43, compared with $5.26 in the second quarter of 2024.
EBITDA was $1.6 billion, or 18.4% of sales, compared with $1.3 billion, or 15.3% of sales, a year earlier.
North America sales fell 6%, while international revenues rose 5%.
Quarterly common dividend increased to $2.00 per share from $1.82.
Enpro reported second-quarter 2025 sales of $288.1 million, up 6.0%, while net income was $26.4 million versus $26.7 million a year earlier and adjusted diluted EPS fell 2.4% to $2.03. The company raised its full-year 2025 guidance, now expecting adjusted EBITDA of $270 million to $280 million and adjusted diluted EPS of $7.60 to $8.10, compared with prior ranges of $262 million to $277 million and $7.00 to $7.70. Higher sales were offset by growth-related operating expenses and foreign exchange headwinds, so shareholders see revenue and guidance improving alongside lower quarterly profit.
Q2 2025 sales of $288.1 million, up 6.0%; adjusted EBITDA of $71.1 million versus $74.0 million, down 3.9%
Diluted EPS of $1.25 versus $1.27; adjusted diluted EPS of $2.03 versus $2.08
Full-year 2025 adjusted EBITDA guidance raised to $270 million-$280 million from $262 million-$277 million
Quarterly dividend of $0.31 per share declared July 31, 2025, payable September 17, 2025
LCI Industries reported second quarter 2025 net sales of $1.1 billion, up 5% year over year, driven by acquired businesses and higher North American RV sales. Net income fell to $58 million, or $2.29 per diluted share, from $61 million, or $2.40, a year earlier, as operating margin narrowed and executive separation costs weighed on results.
Net sales of $1,107.3 million, up 5.0% from $1,054.5 million in the second quarter of 2024
Net income of $57.6 million, or $2.29 per diluted share, versus $2.40 a year earlier; adjusted net income of $2.39 per diluted share excludes $3.2 million in executive separation costs
Adjusted EBITDA of $121.3 million, or 11.0% of net sales, compared with $122.6 million in the second quarter of 2024
Freedman Seating Company acquisition completed, representing approximately $125 million in annual revenue; $62 million in share repurchases made in July and August 2025
UL Solutions reported second-quarter 2025 revenue of $776 million, up 6.3% from a year earlier, with 5.5% organic growth. Net income fell 8.5% to $97 million and diluted EPS fell to $0.45 from $0.50, partly because of a $25 million non-operating divestiture gain in the prior-year quarter. The company affirmed its full-year 2025 outlook, which includes mid single digit constant currency organic revenue growth and an Adjusted EBITDA margin of approximately 24%.
Revenue rose 6.3% to $776 million, including 5.5% organic growth across all segments.
Net income was $97 million, down from $106 million, and diluted EPS was $0.45 versus $0.50; Adjusted Diluted EPS rose 18.2% to $0.52.
Adjusted EBITDA rose 13.9% to $197 million, and the margin expanded 170 basis points to 25.4%.
The full-year 2025 outlook was affirmed, not raised or cut, and the filing cites geopolitical uncertainty that could affect customers.
Fidelity National Information Services reported second-quarter 2025 revenue up 5% to $2.6 billion and adjusted EPS up 1% to $1.36, while its GAAP results showed a loss of $470 million after a $539 million non-cash deferred tax charge tied to its agreement to sell its remaining Worldpay interest. The company raised its full-year 2025 outlook for revenue, Adjusted EBITDA and Adjusted EPS, which matters to shareholders because the GAAP loss is large even as the operating measures improved.
GAAP net loss from continuing operations attributable to common stockholders of $470 million, or $(0.90) per diluted share, including $539 million of non-cash deferred tax expense
Adjusted EPS of $1.36, up 1% from $1.34; revenue up 5% to $2.6 billion; Adjusted EBITDA up 5% to about $1.0 billion
Full-year 2025 Adjusted EPS outlook raised to $5.72 to $5.80, with revenue growth of 4.8% to 5.3%
Repurchased $246 million of shares in the second quarter; reiterated goal of about $1.2 billion of repurchases in 2025
Core Natural Resources reported a second-quarter 2025 net loss of $36.6 million, or $0.70 per diluted share, on revenues of $1,102.4 million, with adjusted EBITDA of $144.3 million. The company generated free cash flow of $131.1 million, returned $87.1 million to stockholders, and raised its annual synergy target to $150 million to $170 million, though Leer South longwall production has yet to resume.
Q2 2025 net loss of $36.6 million, or $0.70 per diluted share; revenues of $1,102.4 million.
Adjusted EBITDA of $144.3 million, including $21.2 million of Leer South fire extinguishment and idle mine costs.
Free cash flow of $131.1 million; $87.1 million returned to stockholders, including $81.9 million in share repurchases.
Annual synergy target raised to between $150 million and $170 million.
Azenta reported fiscal third-quarter 2025 results for the quarter ended June 30, 2025. Revenue from continuing operations was $144 million, flat year over year, while adjusted EBITDA margin rose to 12.3% from 9.7%. A $50 million non-cash impairment charge tied to discontinued operations pushed total diluted EPS to ($1.15), and the company reiterated its full-year fiscal 2025 guidance.
Revenue was $144 million, flat year over year; organic revenue declined 2%.
Diluted EPS from continuing operations was $0.01 versus ($0.00) a year earlier; non-GAAP diluted EPS was $0.19 versus $0.14.
Total diluted EPS was ($1.15) versus ($0.12), including ($1.17) from discontinued operations due to a $50 million non-cash impairment charge.
Full-year fiscal 2025 guidance was reiterated: organic revenue growth of 3% to 5% and adjusted EBITDA margin expansion of about 300 basis points.
Pediatrix Medical Group reported second-quarter 2025 net income of $39.3 million, or $0.46 per diluted share, compared with a net loss of $153.0 million a year earlier, which included impairment charges. Net revenue fell to $468.8 million from $504.3 million, mainly due to practice dispositions, and the company raised its full-year 2025 Adjusted EBITDA outlook to a range of $245 million to $255 million from $220 million to $240 million.
Q2 2025 net revenue was $468.8 million, down from $504.3 million in Q2 2024, mainly due to practice dispositions.
Q2 2025 net income was $39.3 million, or $0.46 per diluted share, versus a net loss of $153.0 million in Q2 2024.
Q2 2025 Adjusted EPS was $0.53, compared with $0.34 a year earlier.
Full-year 2025 Adjusted EBITDA outlook raised to $245 million to $255 million from $220 million to $240 million.
Sally Beauty reported fiscal third-quarter results for the quarter ended June 30, 2025, with net sales of $933.3 million, down 1.0% from a year earlier, while GAAP diluted earnings per share rose 22% to $0.44. The company raised its full-year adjusted operating margin guidance to 8.6% to 8.7% from 8.0% to 8.5%, and its comparable sales outlook moved to approximately flat from flat to down 1%, so profit improved on slightly weaker sales.
Net sales of $933.3 million, down 1.0%; comparable sales decreased 0.4%
GAAP diluted EPS of $0.44 vs. $0.36 a year earlier; adjusted diluted EPS of $0.51 vs. $0.45
Full-year adjusted operating margin guidance raised to 8.6% to 8.7% from 8.0% to 8.5%
Full-year comparable sales outlook now approximately flat, previously flat to down 1%
Easterly Government Properties reported second-quarter 2025 results, with total revenues up to $84.2 million from $76.2 million a year earlier. Net income fell to $4.3 million, or $0.09 per diluted share, from $4.9 million, or $0.11, while Core FFO rose to $34.6 million, or $0.74 per share, from $31.4 million, or $0.72. The company maintained its full-year 2025 Core FFO per share guidance of $2.98 to $3.03 and declared a $0.45 per share dividend.
Q2 2025 total revenues were $84.2 million, versus $76.2 million in Q2 2024.
Q2 2025 net income was $4.3 million ($0.09 per diluted share), versus $4.9 million ($0.11) in Q2 2024.
Full-year 2025 Core FFO per share guidance was maintained at $2.98 to $3.03.
Board approved a $0.45 per share dividend, payable August 25, 2025 to holders of record on August 13, 2025.
Apollo reported second-quarter 2025 results with GAAP net income attributable to common stockholders of $605 million, or $1.00 per share, down from $828 million a year earlier, while total revenues rose to $6,814 million from $6,018 million. Its non-GAAP Adjusted Net Income reached $1.2 billion, or $1.92 per share, versus $1.64 a year earlier, driven by higher fee-related earnings and management fees.
GAAP net income attributable to common stockholders was $605 million ($1.00 basic per share) in Q2 2025, compared with $828 million ($1.36) in Q2 2024.
Fee-related earnings rose 21.5% year over year to $627 million; management fees rose 21.4% to $816 million.
Adjusted Net Income was $1,179 million ($1.92 per share), compared with $1,009 million ($1.64 per share) in Q2 2024.
Declared a $0.51 per share common dividend, payable August 29, 2025, to holders of record on August 18, 2025.
Henry Schein reported second-quarter 2025 results, with GAAP diluted EPS of $0.70 versus $0.80 a year earlier and non-GAAP diluted EPS of $1.10 versus $1.23. Net sales rose 3.3% to $3.2 billion, but the company kept its full-year 2025 guidance unchanged and said it is working with KKR on further shareholder value initiatives.
Q2 2025 GAAP net income was $86 million ($0.70 per diluted share), down from $104 million ($0.80) a year earlier
Q2 2025 net sales were $3.2 billion, up 3.3%; first-half net sales were $6.4 billion, up 1.6%
2025 non-GAAP diluted EPS guidance maintained at $4.80 to $4.94; total sales growth guidance of 2% to 4% unchanged
Company repurchased about 3.7 million shares for $259 million in Q2, including a $223 million accelerated stock repurchase completed in July
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.